634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGEâ¢-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
Fitzgerald, Rebecca C., Di Pietro, Massimiliano, O'Donovan, Maria, Muldrew, Beth, Debiram-Beecham, Irene, Offman, Judith, Baseley, Laura, Smith, Sam G., Aigret, Benoit, Walter, Fiona M., Rubin, Greg,Volume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)31020-9
Date:
May, 2020
File:
PDF, 665 KB
2020